双脱氧核苷在体外对2型人类免疫缺陷病毒（HIV - 2）的抑制作用比对HIV - 1的抑制作用小。
Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1.
作者信息
Richman D D
机构信息
Department of Pathology, University of California San Diego 92093.
出版信息
Antimicrob Agents Chemother. 1987 Dec;31(12):1879-81. doi: 10.1128/AAC.31.12.1879.
Abstract
The antiviral activities of various dideoxynucleosides against LAV strains of human immunodeficiency viruses type 1 (HIV-1) and type 2 (HIV-2) were evaluated. Significantly more 3'-azido-3'-deoxythymidine was required to inhibit the replication of HIV-2 than HIV-1 in three human cell lines. HIV-2 also appeared more resistant than HIV-1 to other dideoxynucleosides. These results suggest that dideoxynucleosides may be less effective in vivo for HIV-2 infection and that a broader range of clinical isolates of human retroviruses should be examined for drug susceptibility in vitro.
摘要
评估了各种双脱氧核苷对1型人类免疫缺陷病毒（HIV-1）和2型人类免疫缺陷病毒（HIV-2）的拉夫（LAV）毒株的抗病毒活性。在三种人类细胞系中，抑制HIV-2复制所需的3'-叠氮基-3'-脱氧胸苷比抑制HIV-1复制所需的要多得多。HIV-2对其他双脱氧核苷的耐药性似乎也比HIV-1更强。这些结果表明，双脱氧核苷在体内对HIV-2感染的效果可能较差，并且应该对更广泛的人类逆转录病毒临床分离株进行体外药敏试验。
相似文献
1
Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1.
Antimicrob Agents Chemother. 1987 Dec;31(12):1879-81. doi: 10.1128/AAC.31.12.1879.
2
Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
Antimicrob Agents Chemother. 1987 Jun;31(6):907-10. doi: 10.1128/AAC.31.6.907.
3
Activities of (-)-carbovir and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro.
Antimicrob Agents Chemother. 1990 Jun;34(6):1297-300. doi: 10.1128/AAC.34.6.1297.
4
Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.
AIDS Res Hum Retroviruses. 1988 Apr;4(2):107-13. doi: 10.1089/aid.1988.4.107.
5
Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine.
J Virol. 1987 Dec;61(12):3769-73. doi: 10.1128/JVI.61.12.3769-3773.1987.
6
Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.
Biochem Biophys Res Commun. 1987 Jan 15;142(1):128-34. doi: 10.1016/0006-291x(87)90460-8.
7
8
Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
J Exp Med. 1987 Oct 1;166(4):1144-9. doi: 10.1084/jem.166.4.1144.
9
Synergistic activity of granulocyte-macrophage colony-stimulating factor and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro.
Antimicrob Agents Chemother. 1987 Jul;31(7):1046-50. doi: 10.1128/AAC.31.7.1046.
10
Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virus.
Lancet. 1987 Apr 18;1(8538):890-2. doi: 10.1016/s0140-6736(87)92862-5.
引用本文的文献
1
An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014.
Acta Pharm Sin B. 2015 Nov;5(6):520-43. doi: 10.1016/j.apsb.2015.09.001. Epub 2015 Nov 2.
2
Antiretroviral drug resistance in human immunodeficiency virus type 2.
Antimicrob Agents Chemother. 2009 Sep;53(9):3611-9. doi: 10.1128/AAC.00154-09. Epub 2009 May 26.
3
Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitro.
Antimicrob Agents Chemother. 2008 Jan;52(1):329-32. doi: 10.1128/AAC.01004-07. Epub 2007 Oct 29.
4
Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.
J Virol. 1997 Jul;71(7):5441-8. doi: 10.1128/JVI.71.7.5441-5448.1997.
5
Human immunodeficiency virus type 2.
CMAJ. 1989 Jan 15;140(2):121-2.
6
Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine.
Antimicrob Agents Chemother. 1989 Jan;33(1):53-7. doi: 10.1128/AAC.33.1.53.
7
Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate.
Antimicrob Agents Chemother. 1988 Nov;32(11):1733-4. doi: 10.1128/AAC.32.11.1733.
8
Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay.
Antimicrob Agents Chemother. 1990 Mar;34(3):436-41. doi: 10.1128/AAC.34.3.436.
9
Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection.
Drugs. 1992 Jul;44(1):94-116. doi: 10.2165/00003495-199244010-00008.
10
Antiretroviral therapy: reverse transcriptase inhibition.
Antimicrob Agents Chemother. 1992 Feb;36(2):245-54. doi: 10.1128/AAC.36.2.245.
本文引用的文献
1
CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.
Cancer. 1965 Apr;18:522-9. doi: 10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j.
2
Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.
Science. 1984 Aug 24;225(4664):840-2. doi: 10.1126/science.6206563.
3
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.
Science. 1984 May 4;224(4648):500-3. doi: 10.1126/science.6200936.
4
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).
Science. 1983 May 20;220(4599):868-71. doi: 10.1126/science.6189183.
5
Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides.
Proc Natl Acad Sci U S A. 1987 Apr;84(8):2469-73. doi: 10.1073/pnas.84.8.2469.
6
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
N Engl J Med. 1987 Jul 23;317(4):192-7. doi: 10.1056/NEJM198707233170402.
7
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
N Engl J Med. 1987 Jul 23;317(4):185-91. doi: 10.1056/NEJM198707233170401.
8
Genome organization and transactivation of the human immunodeficiency virus type 2.
Nature. 1987;326(6114):662-9. doi: 10.1038/326662a0.
9
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
Proc Natl Acad Sci U S A. 1986 Mar;83(6):1911-5. doi: 10.1073/pnas.83.6.1911.
10
Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.
Science. 1985 Aug 9;229(4713):563-6. doi: 10.1126/science.2992081.
Zotero 插件